CG Oncology (CGON) Enterprise Value (2023 - 2025)
Historic Enterprise Value for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to -$680.3 million.
- CG Oncology's Enterprise Value fell 2580.92% to -$680.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$680.3 million, marking a year-over-year decrease of 2580.92%. This contributed to the annual value of -$742.0 million for FY2024, which is 29536.54% down from last year.
- According to the latest figures from Q3 2025, CG Oncology's Enterprise Value is -$680.3 million, which was down 2580.92% from -$661.1 million recorded in Q2 2025.
- In the past 5 years, CG Oncology's Enterprise Value ranged from a high of -$187.7 million in Q4 2023 and a low of -$742.0 million during Q4 2024
- Over the past 3 years, CG Oncology's median Enterprise Value value was -$613.8 million (recorded in 2024), while the average stood at -$577.4 million.
- As far as peak fluctuations go, CG Oncology's Enterprise Value crashed by 29536.54% in 2024, and later plummeted by 1956.52% in 2025.
- CG Oncology's Enterprise Value (Quarter) stood at -$187.7 million in 2023, then crashed by 295.37% to -$742.0 million in 2024, then increased by 8.32% to -$680.3 million in 2025.
- Its Enterprise Value was -$680.3 million in Q3 2025, compared to -$661.1 million in Q2 2025 and -$688.4 million in Q1 2025.